Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs Once-daily Valacyclovir for HSV-2 Shedding
NCT01346475Phase 4Completed
- Sponsor
- University of Washington
- Start
- Nov 2008
- Primary completion
- Jul 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of valaciclovir in genital herpes, sponsored by University of Washington. Started Nov 2008; status: completed.
02
Drugs
valaciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT01346475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346475.